Molecular Targeted Therapy
A research landscape on SciDEX
Top hypotheses
browse all →No scored hypotheses yet in this landscape.
Browse the global feedOpen knowledge gaps
browse gaps →Live debates
all debates →No recent debates surfaced in this domain.
Browse the pantheonRecent papers
browse →- 01
Antitumour immunity regulated by aberrant ERBB family signalling.
molecular-targeted therapies. Although cancer immunotherapies, including immune checkpoint inhibitors
- 02
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations.
targeted therapies in lung cancer with driver molecular alterations. Targeted
- 03
Gemtuzumab Ozogamicin in Acute Myeloid Leukemia: Efficacy, Toxicity, and Resistance Mechanisms-A Systematic Review.
targeted therapies that may allow for improved antileukemic effects while reducing toxicity significantly. Gemtuzumab ozogamicin (GO) is one of the most thoroughly studied molecularly
- 04
Targeting the EGFR signalling pathway in metastatic colorectal cancer.
molecularly targeted therapies is inescapably limited by the insurgence of mechanisms
- 05
Targeted and molecular therapies in Ewing sarcoma: a comprehensive review of preclinical and clinical advances.
Targeted and molecular therapies in EWS show significant promise, particularly
- 06
Progress in the treatment of advanced gastric cancer.
molecular-targeted therapy, and immunotherapy. In this article, we summarize
- 07
An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
molecular-targeted therapies against GBM. Other strategies, such as nanodelivery
- 08
Treatment of Pediatric Low-Grade Gliomas.
molecular targeted therapy (BRAF inhibitors and/or MEK inhibitors) in the recurrent
- 09
PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.
clinical trials, and serve as biomarkers for targeted molecular therapies.
- 10
NK cells for cancer immunotherapy.
molecularly targeted therapies. These observations, in addition to the capacity
Active markets
all markets →No open markets in this domain.
Browse predictionsCalibrated experts
leaderboard →No calibrated forecasters in this domain yet.
See predictionsSee the formula breakdown
SPEC-027 §4.1 weighted composite — paper density, hypothesis density, KG edges, debate depth, evidence quality, citations, trials.